- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04605016
Clinical Performance of Dentals Implants With Hydrophilic or Hydrophobic Surfaces
May 8, 2023 updated by: Cláudio Rodrigues Leles, Universidade Federal de Goias
Clinical Performance of Dental Implants With Hydrophilic or Hydrophobic Surfaces in Single Posterior Edentulous Spaces: a Randomized Clinical Trial
The aim of the study is to compare longitudinally the clinical performance of dental implants with different surfaces placed in single tooth gaps at the posterior maxilla and mandible of adults.
It is a randomized clinical trial, in which participants will be randomly allocated to two groups: test group (implants with hydrophilic surface) and control group (implants with hydrophobic surface).
The null hypothesis is that the implant stability quotient of hydrophilic and hydrophobic dental implants show a similar progression after placement in posterior tooth gaps.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Claudio R Leles, PhD
- Phone Number: +55 062 32906052
- Email: claudio_leles@ufg.br
Study Contact Backup
- Name: Ana Ferreira, MsC
- Email: caru_moraes@hotmail.com
Study Locations
-
-
Goias
-
Goiania, Goias, Brazil
- Faculty of Dentistry of the Federal University of Goias
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Present single or multiple intercalated untreated tooth gaps in the posterior region of the mandible or maxilla;
- Agree to participate in the study by signing the informed consent form.
Exclusion Criteria:
- Unavailability for participation or signs that they could not comply with the schedule of follow-up visits;
- Presence of general and/or local contraindications that could prevent the surgical procedure for implant placement;
- Presence of conditions that may interfere with the prognosis, such as current treatment with bisphosphonates or report of use for less than 2 years, presence of rheumatic diseases, among others;
- Absence of the minimum bone quantity of 8 mm in length and 3.75 mm in diameter for installation of an implant in the tooth gap;
- Absence of a mesio-distal space of at least 4.6 mm in the single tooth gap required to place the surgical guide;
- Do not present a mouth opening of at least 12mm required for the proper of the guided surgical kit together with the surgical guide;
- Do not present a band of keratinized tissue favorable for maintaining peri-implant health.
- Present motor difficulties that compromise adequate oral hygiene.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Hydrophilic surface implants
|
A dental implant with hydrophilic surface will be placed and restored in single-tooh gaps of the posterior region of the mandible or maxilla.
Other Names:
|
Active Comparator: Hydrophobic surface implants
|
A dental implant with hydrophobic surface will be placed and restored in single-tooh gaps of the posterior region of the mandible or maxilla.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of implant stability
Time Frame: 10 time-points will be considered and divided in two phases: surgical and prosthetic. The last measure will occur 1 year after the placement of the definitive implant restoration.
|
Implant stability was set as the primary outcome.
The implant stability quotient (ISQ) will be measured using a portable device called Osstell ISQ (Osstell Mentor, Integration Diagnostics, Göteborg, Sweden).
|
10 time-points will be considered and divided in two phases: surgical and prosthetic. The last measure will occur 1 year after the placement of the definitive implant restoration.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Implant success
Time Frame: Assessed at the 12-month follow-up visit.
|
Each implant will be assessed according to the health scale of the International Congress of Oral Implantologists (ICOI-Pisa health scale).
After clinical assessment, each implant will be classified as 'success', 'satisfactory survival', 'compromised survival' or 'failure'.
|
Assessed at the 12-month follow-up visit.
|
Periimplant bone level
Time Frame: Radiographs will be obtained at 4 time points: immediately after implant placement, at the session of the provisional prosthesis installation, and at the 6 and 12-month follow-up visits after the delivery of the definitive prosthesis.
|
Periapical radiographs will be obtained and the periimplant bone level will be measured and compared longitudinally.
|
Radiographs will be obtained at 4 time points: immediately after implant placement, at the session of the provisional prosthesis installation, and at the 6 and 12-month follow-up visits after the delivery of the definitive prosthesis.
|
Condition of the periimplant soft tissues
Time Frame: 15-days, 6- and 12-month follow-up visits after delivery of the definitive prosthesis.
|
The following parameters will be assessed clinically: presence/absence of bleeding on probing, probing depth, and presence/absence suppuration.
|
15-days, 6- and 12-month follow-up visits after delivery of the definitive prosthesis.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2021
Primary Completion (Anticipated)
September 11, 2023
Study Completion (Anticipated)
December 30, 2023
Study Registration Dates
First Submitted
October 15, 2020
First Submitted That Met QC Criteria
October 24, 2020
First Posted (Actual)
October 27, 2020
Study Record Updates
Last Update Posted (Actual)
May 10, 2023
Last Update Submitted That Met QC Criteria
May 8, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI04791-2020
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tooth Loss
-
Institut Straumann AGCompleted
-
University of AarhusCompleted
-
Duygu KarasanHacettepe UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Cairo UniversityNot yet recruitingLoss of Teeth Due to ExtractionEgypt
-
Eisenhower Army Medical CenterUnknownLoss of Teeth Due to ExtractionUnited States
-
The University of Texas Health Science Center at...Osteogenics BiomedicalCompletedLoss of Teeth Due to Extraction
-
Institut Straumann AGTerminated
-
Heidelberg UniversityCompletedTooth Loss, Teeth Replaced Using All Ceramic FPDsGermany
-
Inesa AstramskaitėCompletedAnxiety | Fear | Teeth, Impacted | Tooth-lossLithuania
Clinical Trials on Hydrophilic surface implants
-
Aydin Adnan Menderes UniversityCompletedDental ImplantationTurkey
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingOpen Fractures, Degenerative Osteoarthritis and Degenerative Spinal Diseases
-
Queen Mary University of LondonUniversity of ZurichRecruitingBiomarkers | Dental Implant | Saliva | Guided Bone RegenerationUnited Kingdom
-
Hams Hamed AbdelrahmanNot yet recruitingOsteointegrationEgypt
-
Malo ClinicNobel BiocareActive, not recruitingEdentulous JawPortugal
-
Unicon Optical Co. Ltd.Completed
-
Bio-medical Carbon Technology Co., Ltd.China Medical University HospitalCompleted
-
EyeKon Medical, Inc.Withdrawn
-
University of Geneva, SwitzerlandCompleted
-
Szabocsik and Associates, Inc.Completed